These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7157229)

  • 1. Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteins.
    Fougnot C; Jozefowicz M; Bara L; Samama M
    Thromb Res; 1982 Oct; 28(1):37-46. PubMed ID: 7157229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalysis of the generation of thrombin-antithrombin complex by insoluble anticoagulant polystyrene derivatives.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1984 Mar; 5(2):94-9. PubMed ID: 6722255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant activity of amino acid modified polystyrene resins: influence of the carboxylic acid function.
    Fougnot C; Dupillier MP; Jozefowicz M
    Biomaterials; 1983 Apr; 4(2):101-4. PubMed ID: 6860750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: I. In vitro adsorption studies.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1983 Oct; 4(4):294-8. PubMed ID: 6640057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition.
    Charef S; Tapon-Bretaudière J; Fischer AM; Pflüger F; Jozefowicz M; Labarre D
    Biomaterials; 1996 May; 17(9):903-12. PubMed ID: 8718936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New heparin-like insoluble materials: part II.
    Fougnot C; Jozefowicz M; Samama M; Bara L
    Ann Biomed Eng; 1979; 7(5-6):441-50. PubMed ID: 549503
    [No Abstract]   [Full Text] [Related]  

  • 7. New heparin-like insoluble materials: part I.
    Fougnot C; Jozefonvicz J; Samama M; Bara L
    Ann Biomed Eng; 1979; 7(5-6):429-39. PubMed ID: 549502
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin-like activity of insoluble sulphonated polystyrene resins. Part I: Influence of the surface density, nature and binding of substituted anionic groups.
    Kanmangne FM; Labarre D; Serne H; Jozefowicz M
    Biomaterials; 1985 Sep; 6(5):297-302. PubMed ID: 4052545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity of antithrombin III for insoluble modified polystyrene.
    Boisson C; Gulino D; Jozefonvicz J
    Thromb Res; 1987 Apr; 46(1):101-8. PubMed ID: 3590108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmatic antiproteinase activity enhancement by insoluble functionalized polystyrene surfaces.
    Charef S; Jozefowicz M; Labarre D; Tapon-Bretaudiere J; Fischer AM; Bros A
    Biomaterials; 1990 Aug; 11(6):425-9. PubMed ID: 2207233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adsorption of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: II. Competition with the other plasma proteins.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1984 Mar; 5(2):89-93. PubMed ID: 6722254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-like tubings. II. Mechanism of the thrombin-antithrombin III reaction at the surface.
    Migonney V; Fougnot C; Jozefowicz M
    Biomaterials; 1988 May; 9(3):230-4. PubMed ID: 3408793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adsorption of thrombin from buffer and modified plasma to polystyrene resins containing sulphonate and sulphamide arginyl methyl ester groups.
    Boisson C; Jozefonvicz J; Brash JL
    Biomaterials; 1988 Jan; 9(1):47-52. PubMed ID: 3349121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of human platelets with insoluble anticoagulant modified polystyrene resins.
    Fougnot C; Lindon J; Kirshner L; Salzman EW; Jozefowicz M
    Biomaterials; 1984 May; 5(3):169-74. PubMed ID: 6733220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombic properties of insoluble modified polystyrene: Part I.
    Boisson C; Gulino D; Jozefonvicz J; Fischer AM; Tapon-Bretaudiere J
    Thromb Res; 1984 May; 34(4):269-76. PubMed ID: 6740563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-like activity of insoluble sulphonated polystyrene resins. Part III: Binding of dicarboxylic amino acids.
    Douzon C; Kanmangne FM; Serne H; Labarre D; Jozefowicz M
    Biomaterials; 1987 May; 8(3):190-4. PubMed ID: 3607151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adsorption of plasma proteins onto anticoagulant polystyrene derivatives: a fluorescence study.
    Dulos E; Dufourcq J; Fougnot C; Jozefowicz M
    Biomaterials; 1988 Sep; 9(5):405-12. PubMed ID: 3224125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of proteins in human plasma with modified polystyrene resins.
    Boisson-Vidal C; Jozefonvicz J; Brash JL
    J Biomed Mater Res; 1991 Jan; 25(1):67-84. PubMed ID: 2019612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
    Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
    Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.